Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$334K Buy
119,455
+2,356
+2% +$6.36K ﹤0.01% 1077
2023
Q3
$302K Buy
117,099
+7,294
+7% +$21.1K ﹤0.01% 1070
2023
Q2
$349K Hold
109,805
﹤0.01% 1041
2023
Q1
$310K Buy
+109,805
New +$287K ﹤0.01% 1078
2015
Q4
Sell
-413,784
Closed -$2.03M 1443
2015
Q3
$2.03M Buy
+413,784
New +$2.25M ﹤0.01% 986
2014
Q2
Sell
-190,314
Closed -$1.41M 1454
2014
Q1
$1.41M Sell
190,314
-3,891
-2% -$27.2K ﹤0.01% 1126
2013
Q4
$1.43M Buy
+194,205
New +$1.42M ﹤0.01% 1130

Other funds holding ABEV

Putnam Investments's ABEV Position: Q4 2023 in Review

Putnam Investments increased its Ambev (ABEV) stake by 2% in Q4 2023, buying an estimated $6.36K and bringing the position to 119,455 shares worth $334K. The position accounts for ﹤0.01% of the portfolio, ranked #1077.

Putnam Investments first reported a position in ABEV in Q4 2013 and has held it in 7 quarters since. The position peaked at $2.03M in Q3 2015. 345 funds tracked by Wall St. Rank hold ABEV as of Q4 2023.

  • Putnam Investments held 119,455 shares of Ambev worth $334K as of Q4 2023.
  • Putnam Investments bought 2,356 Ambev shares in Q4 2023, an estimated $6.36K.
  • Ambev made up ﹤0.01% of Putnam Investments's portfolio in Q4 2023, its #1077 holding.
  • Putnam Investments first reported a position in Ambev in Q4 2013 and has held it in 7 quarters since.
  • Putnam Investments's Ambev position peaked at $2.03M in Q3 2015.
  • 345 funds tracked by Wall St. Rank held Ambev as of Q4 2023.

Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.